Systemic Score Predicts Still's Disease Severe ComplicationsJanuary 1, 1970A multinational study of adults with Still’s disease found that calculating their systemic score…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Polyautoimmunity: axSpA and Familial Mediterranean FeverJanuary 1, 1970Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Infection or Disease Flare: What Tools Can Help Differentiate?January 1, 1970Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…View Resource Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Telemedicine Enriched Care Model for Autoinflammatory DiseasesJanuary 1, 1970Autoinflammatory diseases arise through inappropriate activation of antigen-independent inflammatory mechanisms and can have a…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Emapalumab for the treatment of macrophage activation syndromeJanuary 1, 1970Macrophage activation syndrome (MAS) is a term commonly used by rheumatologists to describe a…View Resource Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Cytokine Inhibitor Lung Disease in Still's Linked to HLA-DRB1 AllelesJanuary 1, 1970Pulmonary complications in the setting of Still’s disease (both juvenile and adult) has seldom…View Resource Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource 12345…678
Risks associated with mortality in VEXASJanuary 1, 1970Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…View Resource